Related Experiment Video
Updated: Feb 18, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Triterpenoids with antiplatelet aggregation activity from Ilex rotunda
Bao Yang1, Jin-Ping Zhu1, Li Rong1
1School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Researchers isolated seven new triterpenoids from Ilex rotunda barks, with some showing moderate antiplatelet aggregation effects. These findings contribute to understanding the plant
Area of Science:
- Natural Product Chemistry
- Pharmacology
Background:
- Ilex rotunda Thunb. is a plant source of bioactive compounds.
- Triterpenoids are a diverse class of natural products with various biological activities.
Purpose of the Study:
- To isolate and characterize novel triterpenoids from Ilex rotunda barks.
- To evaluate the antiplatelet aggregation activity of the isolated compounds.
Main Methods:
- Phytochemical isolation using spectroscopic analysis (NMR, MS).
- Structural elucidation of new compounds.
- High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC) for sugar moiety identification.
- In vitro antiplatelet aggregation assay using adenosine diphosphate (ADP) induced rat platelets.
Main Results:
- Seven new triterpenoids, rotundinosides E-K, were isolated along with sixteen known compounds.
- Rotundinoside F exhibited a rare triterpene-phenylpropanoid hybrid structure.
- Rotundinoside H possessed an unusual triterpene saponin structure with an α-linked glucopyranosyl moiety.
- Five compounds demonstrated moderate inhibitory effects on platelet aggregation, with IC50 values between 22.4–32.8 μM.
Conclusions:
- The study successfully identified novel triterpenoids from Ilex rotunda.
- Some isolated compounds, particularly rotundinoside F and H, possess unique structural features.
- The identified compounds show potential as antiplatelet agents, warranting further investigation.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Clot Retraction and Fibrinolysis
Drugs for Treatment of Constipation-Predominant IBS
Drugs that Stabilize Microtubules

